V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001070 | 230000640 | 1.76 | 87 | Disease modification (D) | 2016-10-21 | 2016-11-11 | Irinotecan + Modified De Gramont | N | N | 230016570 | FLUOROURACIL |
| 230001071 | 230000640 | null | null | Palliative (P) | 2018-05-31 | 2018-06-02 | Oxaliplatin + Modified de Gramont | N | null | 230016570 | CVP R |
| 230001072 | 230000642 | 1.5 | 84 | Palliative (P) | 2016-07-19 | 2016-07-21 | AFLIBERCEPT + FU + IRINOTECAN | 02 | Y | 230016762 | CAPECITABINE |
| 230001073 | 230000642 | 1.74 | 97.5 | Palliative (P) | 2014-12-08 | 2015-08-18 | Bevacizumab + Oxaliplatin +MdG | N | N | 230016762 | CETUXIMAB + IRINOTECAN + MDG |
| 230001074 | 230000642 | 1.66 | 89.1 | Curative (C) | 2017-10-09 | 2017-10-23 | Capecitabine + Oxaliplatin 21day | N | N | 230016762 | CAPECITABINE + OXALIPLATIN |
| 230001075 | 230000644 | 1.66 | 70.6 | Curative (C) | 2017-10-04 | 2017-10-30 | Oxaliplatin + Modified de Gramont | 2 | null | 230017336 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 230001076 | 230000645 | 1.78 | 75.7 | Adjuvant (A) | 2014-05-11 | 2014-06-01 | Fluorouracil+Mitomycin+RT (Bladder) | null | N | 230017358 | CAPECITABINE + OXALIPLATIN |
| 230001077 | 230000645 | 0 | 85.2 | Not known (9) | 2017-03-20 | 2017-03-25 | Trifluridine + Tipiracil | null | Y | 230017358 | IRINOTECAN + MDG |
| 230001078 | 230000646 | null | null | null | 2018-03-14 | 2018-07-02 | PEMBROLIZUMAB | N | null | 230017679 | FLUOROURACIL |
| 230001079 | 230000646 | 1.63 | 61.1 | Palliative (P) | 2017-11-13 | 2018-02-16 | FLUOROURACIL + OXALIPLATIN | 2 | N | 230017679 | TRASTUZUMAB |
| 230001080 | 230000647 | 1.86 | 84.7 | Palliative (P) | 2016-06-20 | 2016-06-24 | Capecitabine + Oxaliplatin 21day | N | N | 230018235 | OXALIPLATIN + MDG |
| 230001081 | 230000647 | 1.79 | 128 | Curative (C) | 2018-01-31 | 2018-02-09 | Carboplatin + Pemetrexed | 02 | N | 230018235 | CAPECITABINE + OXALIPLATIN |
| 230001082 | 230000649 | null | 59 | Palliative (P) | 2015-12-25 | 2016-01-06 | Capecitabine | null | null | 230018378 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 230001083 | 230001563 | 1.67 | 92.3 | Not known (9) | 2013-05-31 | 2013-05-31 | Oxaliplatin + Modified de Gramont | N | null | 230018510 | CAPECITABINE + OXALIPLATIN |
| 230001084 | 230001563 | 1.73 | 75.4 | Palliative (P) | 2015-08-18 | 2015-11-11 | Carboplatin + Etoposide iv&po | 02 | N | 230018510 | BEVACIZUMAB + FLUOROURACIL |
| 230001085 | 230001298 | 1.82 | 0 | Palliative (P) | null | 2017-09-14 | CAPECITABINE + OXALIPLATIN | N | null | 230018912 | MPT |
| 230001086 | 230000652 | 1.73 | 59.4 | Palliative (P) | 2014-06-02 | 2014-06-02 | Irinotecan + Modified De Gramont | N | N | 230019077 | CETUXIMAB + IRINOTECAN + MDG |
| 230001087 | 230000655 | null | 73.6 | Palliative (P) | 2017-12-12 | 2017-12-29 | MPT | 02 | N | 230019300 | OXALIPLATIN + MDG |
| 230001088 | 230000656 | 1.8 | null | Palliative (P) | 2017-01-17 | 2017-01-24 | Bevacizumab | N | null | 230019471 | CAPECITABINE |
| 230001089 | 230000657 | 1.64 | null | Curative (C) | 2018-05-09 | 2018-05-09 | CYTARABINE | N | N | 230019732 | OXALIPLATIN + MDG |
| 230001090 | 230000658 | null | 48.2 | Neo-adjuvant (N) | 2015-12-10 | 2015-12-20 | GemCarbo Days 1+8 | 02 | N | 230019732 | IRINOTECAN + MDG |
| 230001091 | 230000661 | 1.8 | 86.2 | null | 2014-03-24 | 2014-04-13 | Oxaliplatin + Modified de Gramont | N | N | 230020525 | CETUXIMAB + OXALIPLATIN + MDG |
| 230001092 | 230000661 | 1.78 | 67 | Palliative (P) | 2017-09-29 | 2017-09-29 | PIXANTRONE | N | null | 230020525 | CETUXIMAB |
| 230001093 | 230000662 | 1.66 | 97.499 | Adjuvant (A) | 2013-07-31 | 2013-07-31 | FLUOROURACIL + OXALIPLATIN | N | N | 230020870 | FLUOROURACIL |
| 230001094 | 230000663 | 1.6 | 63.6 | Adjuvant (A) | 2014-01-21 | 2014-01-26 | FLUOROURACIL + OXALIPLATIN | null | N | 230020870 | FEC |
| 230001095 | 230000664 | 1.65 | 53 | Palliative (P) | 2015-12-07 | 2016-06-06 | Oxaliplatin + Modified de Gramont | N | N | 230021348 | OXALIPLATIN + MDG |
| 230001096 | 230000668 | 1.53 | null | Adjuvant (A) | 2015-08-14 | 2015-08-27 | TRASTUZUMAB | 2 | N | 230021354 | FLUOROURACIL |
| 230001097 | 230000669 | 1.63 | 54 | Palliative (P) | 2014-07-14 | 2016-04-20 | Capecitabine + Oxaliplatin 21day | N | N | 230021580 | SORAFENIB |
| 230001098 | 230000670 | null | 59.6 | Adjuvant (A) | 2017-01-01 | 2017-01-02 | BCG Intravesical | 02 | N | 230021651 | OXALIPLATIN + MDG |
| 230001099 | 230000671 | 1.84 | null | Not known (9) | 2014-09-24 | 2014-10-06 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 230022008 | IRINOTECAN + MDG |
| 230001100 | 230001304 | 1.75 | 60.65 | Curative (C) | 2016-10-21 | 2016-11-14 | CAPECITABINE + RT | 2 | N | 230022010 | OXALIPLATIN + MDG |
| 230001101 | 230001566 | 1.83 | 99 | Disease modification (D) | 2019-01-27 | 2019-02-09 | Capecitabine + Oxaliplatin 21day | 2 | N | 230022131 | FLUOROURACIL |
| 230001102 | 230000673 | 1.71 | 85.2 | null | 2014-10-20 | 2014-11-12 | Fluorouricil + Folonic Acid (MdG) | 02 | null | 230022136 | CETUXIMAB + IRINOTECAN + MDG |
| 230001103 | 230000674 | 1.7 | 61.1 | Palliative (P) | 2016-12-19 | 2017-05-01 | FEC | N | N | 230022180 | CAPECITABINE + OXALIPLATIN |
| 230001104 | 230000675 | 1.66 | 81.8 | Palliative (P) | 2018-07-22 | 2018-08-13 | Fluorouracil + Folinic Acid Weekly | N | N | 230022180 | OXALIPLATIN + MDG |
| 230001105 | 230000676 | 1.73 | null | Disease modification (D) | 2013-12-28 | 2013-12-31 | Capecitabine + Oxaliplatin 21day | 02 | N | 230022508 | OXALIPLATIN + MDG |
| 230001106 | 230000677 | 1.73 | 73.9 | Palliative (P) | 2015-07-10 | 2015-07-10 | BEVACIZUMAB + FLUOROURACIL | 02 | Y | 230022553 | CAPECITABINE + IRINOTECAN |
| 230001107 | 230000679 | 1.72 | 71.6 | Disease modification (D) | 2015-08-10 | 2015-08-11 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 230022833 | CAPECITABINE |
| 230001108 | 230000679 | 1.73 | null | Palliative (P) | 2018-11-30 | 2019-02-12 | Methotrexate High Dose (3g/m2) | 02 | N | 230022833 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 230001109 | 230000680 | 1.61 | null | Palliative (P) | 2015-12-12 | 2016-01-21 | FLUOROURACIL + IRINOTECAN | N | null | 230022891 | IRINOTECAN + MDG |
| 230001110 | 230000682 | 1.61 | 61.7 | Palliative (P) | 2013-09-06 | 2013-09-20 | AFLIBERCEPT + FU + IRINOTECAN | N | null | 230023028 | ABIRATERONE |
| 230001111 | 230000685 | 1.65 | 71 | Palliative (P) | 2016-07-09 | 2016-07-09 | Trastuzumab 21 day maintenance | N | N | 230023028 | CAPECITABINE + OXALIPLATIN |
| 230001112 | 230000686 | 1.58 | 74.9 | Palliative (P) | 2014-10-29 | 2014-10-29 | Paclitaxel 80mg/m2 day 1 8 15 | 99 | N | 230023589 | TRIAL |
| 230001113 | 230000686 | 1.69 | 62.1 | Adjuvant (A) | null | 2017-05-25 | DA-EPOCH-R | N | N | 230023589 | CETUXIMAB + OXALIPLATIN + MDG |
| 230001114 | 230000687 | 1.5 | 67.2 | Palliative (P) | 2016-01-14 | 2017-11-12 | Cetuximab + FOLFIRI cycle 2 onwards | N | Y | 230024143 | OXALIPLATIN + MDG |
| 230001115 | 230000692 | null | 63 | Palliative (P) | 2015-12-30 | 2015-12-30 | FLUOROURACIL + IRINOTECAN | N | N | 230024406 | OXALIPLATIN + MDG |
| 230001116 | 230000693 | 1.77 | 97.6 | Palliative (P) | null | 2014-07-30 | FLUOROURACIL + IRINOTECAN | 2 | N | 230024456 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 230001117 | 230000695 | 1.8 | 73.15 | Palliative (P) | 2017-04-01 | 2017-04-01 | Irinotecan + Modified De Gramont | 02 | N | 230024684 | OXALIPLATIN + RALTITREXED |
| 230001118 | 230000697 | 1.61 | 76.2 | Palliative (P) | 2017-05-06 | 2017-05-06 | FLUOROURACIL + OXALIPLATIN | 02 | N | 230024715 | CAPECITABINE + OXALIPLATIN |
| 230001119 | 230000698 | 1.79 | 85.2 | Adjuvant (A) | 2017-04-09 | 2017-05-14 | Methotrexate intrathecal | N | N | 230024788 | OXALIPLATIN + MDG |